Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Leutz

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Nature|December 18, 1986
The c-erb-A protein is a high-affinity receptor for thyroid hormoneJ Sap, A Muñoz, K Damm, et al.
Oncogene|June 11, 1999
The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulatorsR Dechend, F Hirano, K Lehmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1992
Constitutive monocyte-restricted activity of NF-M, a nuclear factor that binds to a C/EBP motifJ G Haas, M Ströbel, A Leutz, et al.
The British Journal of Dermatology|August 4, 2019
A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatmentK Reich, M Augustin, D Thaçi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 1997
Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoproteinP Dhordain, O Albagli, R J Lin, et al.
Cell|May 9, 1986
v-mil induces autocrine growth and enhanced tumorigenicity in v-myc-transformed avian macrophagesT Graf, F von Weizsaecker, S Grieser, et al.
The EMBO Journal|January 1, 1989
Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin 6 and granulocyte colony stimulating factorA Leutz, K Damm, E Sterneck, et al.
The British Journal of Dermatology|September 17, 2020
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatmentA Leutz, A Pinter, D Thaçi, et al.
Oncogene|December 21, 1995
The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivoP Dhordain, O Albagli, S Ansieau, et al.
Cell|January 15, 1988
v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) geneM Zenke, P Kahn, C Disela, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Nature|December 18, 1986
The c-erb-A protein is a high-affinity receptor for thyroid hormoneJ Sap, A Muñoz, K Damm, et al.
Oncogene|June 11, 1999
The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulatorsR Dechend, F Hirano, K Lehmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1992
Constitutive monocyte-restricted activity of NF-M, a nuclear factor that binds to a C/EBP motifJ G Haas, M Ströbel, A Leutz, et al.
The British Journal of Dermatology|August 4, 2019
A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatmentK Reich, M Augustin, D Thaçi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 1997
Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoproteinP Dhordain, O Albagli, R J Lin, et al.
Cell|May 9, 1986
v-mil induces autocrine growth and enhanced tumorigenicity in v-myc-transformed avian macrophagesT Graf, F von Weizsaecker, S Grieser, et al.
The EMBO Journal|January 1, 1989
Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin 6 and granulocyte colony stimulating factorA Leutz, K Damm, E Sterneck, et al.
The British Journal of Dermatology|September 17, 2020
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatmentA Leutz, A Pinter, D Thaçi, et al.
Oncogene|December 21, 1995
The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivoP Dhordain, O Albagli, S Ansieau, et al.
Cell|January 15, 1988
v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) geneM Zenke, P Kahn, C Disela, et al.
Pageof 6